The ELSA trial: single versus combinatory effects of non-prohibited beta-2 agonists on skeletal muscle metabolism, cardio-pulmonary function and endurance performance—study protocol for a randomized 4-way balanced cross-over trial

Peer Review reports

Original Submission
6 Jul 2021	Submitted	Original manuscript
9 Nov 2021	Reviewed	Reviewer Report - Kirsty Loudon
19 Nov 2021	Author responded	Author comments - Martina Zügel
Resubmission - Version 2
19 Nov 2021	Submitted	Manuscript version 2
22 Nov 2021	Author responded	Author comments - Martina Zügel
Resubmission - Version 3
22 Nov 2021	Submitted	Manuscript version 3
Publishing
22 Nov 2021	Editorially accepted
11 Dec 2021	Article published	10.1186/s13063-021-05862-w

Back to article page